Emergent BioSolutions Inc. (NYSE:EBS) Q2 2023 Earnings Call Transcript

Emergent BioSolutions Inc. (NYSE:EBS) Q2 2023 Earnings Call Transcript August 8, 2023

Emergent BioSolutions Inc. misses on earnings expectations. Reported EPS is $-1.06 EPS, expectations were $0.98.

Operator: Good day and thank you for standing by. Welcome to the Q2 2023 Emergent BioSolutions Inc. Earnings Conference Call. [Operator Instructions]. Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker, Matt Hartwig.

Matt...